Samples from a patient who recently developed the first severe case of H5N1 bird flu in the U.S. showed mutations that may make it easier for the virus to bind to cell receptors in the human upper ...
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U.S. Food and Drug Administration (FDA) ...